[ad_1]
Laima Ambrozaitytė, associate professor at the Department of Human and Medical Genetics at the Institute of Biomedical Sciences, said on Information Day that the main objective of the study is to assess the diversity of the liquidators of the Chernobyl disaster in Lithuania and find:
“More than 7,000 people were sent from Lithuania to liquidate the disaster. It is estimated that slightly less than half of them are alive today. It is true that there is no active registry so we can know each and every one of them. We are cooperating with the Lithuanian Chernobyl movement, where there are somewhat more active groups of liquidators. To date, only 115 subjects have been included in the study. “
At present, says L. Ambrozaitytė, the focus is on the investigation of people who were directly involved in the liquidation processes of the catastrophe. Although the study is still ongoing, the first ideas are already surprising:
“In the group in which we have included the subjects, the proportion of oncological diseases is not that great compared to the general statistics of Lithuania. We have also taken note of eye and tooth pathologies, which we have linked to genome variations in association research. “
Another aspect that surprised the scientists is L. Ambrozaitytė: there were not many infectious diseases among the subjects, which contradicts the direct causality of the high ionizing radiation.
“Our main goal is to find that combination in the genome, which has led to these people being able to adapt even after experiencing such factors,” says the researcher. The data disclosed in the study may help address human health problems in the future.
[ad_2]